Thu May 28 01:37:51 SGT 2015  
HEPATITIS
B
    Hepatitis B, Philippines
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment
28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing

Hepatitis B, Philippines

Summary

Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Immunochromatographic assay for quantitative and sensitive detection of hepatitis B virus surface antigen using highly luminescent quantum dot-beads.
Wed, 27 May 2015 14:00:16 +0100 | Talanta
In this study, we used highly luminescent quantum dot-beads (QBs) as signal amplification probes in the sandwich immunochromatographic assay (ICA) for ultrasensitive and quantitative detection of hepatitis B virus surface antigen (HBsAg) in human serum. Various parameters that influenced the sensitivity and stability of the QB-based ICA (QB-ICA) sensor were investigated. Two linear independent regression equations for detection of serum HBsAg were expressed with Y=0.3361X-0.0059 (R(2)=0.9983) for low HBsAg concentrations between 75pgmL(-1) and 4.8ngmL(-1), and Y=0.8404 X-2.9364 (R(2)=0.9939) for high HBsAg concentrations in the range from 4.8ngmL(-1) to 75ngmL(-1). The detection limit of the proposed ICA sensor achieved was 75pgmL(-1), which is much higher than that of the routinely-used g...

GlobeImmune hepatitis B drug test disappoints, stock tanks
Wed, 27 May 2015 13:17:06 +0100 | bizjournals.com Health Care:Pharmaceuticals headlines
GlobeImmune Inc. said its experimental hepatitis B drug "did not show a reduction" of the disease in a recent 24-week study causing shares of the Louisville biotech to plummet early Wednesday trading.

GlobeImmune, Gilead Hepatitis B drug fails in mid-stage study
Wed, 27 May 2015 12:07:49 +0100 | Reuters: Health
(Reuters) - GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial. (Source: Reuters: Health)

Increased Pygo2 expression in liver of patients with hepatitis B virus related fibrosis
Wed, 27 May 2015 10:27:16 +0100 | Liver International
ConclusionsThis study suggested that Pygo2 was involved in HBV‐induced liver fibrogenesis. Pygo2 is a valuable biomarker for the evaluation of fibrosis in HBV‐infected patients.This article is protected by copyright. All rights reserved. (Source: Liver International)

Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial‐embolization prognostic score
Tue, 26 May 2015 11:56:09 +0100 | Liver International
ConclusionsAlthough the HAP score predicted OS for Korean subjects with HCC undergoing TACE, the addition of tumor number significantly improved the prognostic performance. The mHAP‐II score can be used for accurate prognostication and selection of optimal candidates for TACE.This article is protected by copyright. All rights reserved. (Source: Liver International)

Decreased blood hepatitis B surface antibody levels linked to e-waste lead exposure in preschool children
Tue, 26 May 2015 00:00:00 +0100 | Journal of Hazardous Materials
Publication date: 15 November 2015 Source:Journal of Hazardous Materials, Volume 298 Author(s): Xijin Xu , Xiaojuan Chen , Jian Zhang , Pi Guo , Tingzao Fu , Yifeng Dai , Stanley L. Lin , Xia Huo Lead (Pb) is a widespread environmental contaminant that can profoundly affect the immune system in vaccinated children. To explore the association between blood Pb and HBsAb levels in children chronically exposed to Pb, we measured hepatitis B surface antibody (HBsAb) titers, to reflect the immune response in the children of Guiyu, an electronic and electrical waste (e-waste) recycling area well known for environmental Pb contamination. We performed secondary exploratory analyses of blood Pb levels and plasma HBsAb titers in samples, taken in two phases between 2011 and 2012, from 590 children ...

Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch‐Up, and Check Again!
Tue, 26 May 2015 00:00:00 +0100 | American Journal of Transplantation
(Source: American Journal of Transplantation)

Non-injected illicit drug use and infectious disease risk of donor tissue: a single institution retrospective review
Tue, 26 May 2015 00:00:00 +0100 | Cell and Tissue Banking
This study assessed the relationship of non-injected illicit drug use and infectious disease seropositivity for human immunodeficiency virus (HIV-1), hepatitis B virus (HBV), hepatitis C virus (HCV), and Syphilis. In a retrospective review of 986 donor charts recovered from 2009 to 2011 at a single tissue bank, the absence of reported non-injected illicit drug use corresponded with seropositivity in 6.61 %, of recovered donors while reported illicit drug use in the medical and social history corresponded with seropositivity in 11.25 %, representing a 70 % increased risk. There was no significant difference noted for overall seropositivity rates between types on noninjected illicit drugs, although donors that used cocaine had a higher incidence of HIV, while marijuana use was associated ...

Hepatitis B virus infection and gastric cancer risk: pitfalls in the potential association
Tue, 26 May 2015 00:00:00 +0100 | British Journal of Cancer
Authors: X-Z Chen, R Wang & J-K Hu (Source: British Journal of Cancer)

Abdominal Pain Caused by Spontaneous Rupture of a Liver Tumor
Tue, 26 May 2015 00:00:00 +0100 | Gastroenterology
Question: A 47-year-old man was admitted to our hospital with an 8-hour history of intermittent abdominal pain that had developed suddenly. He had a history of liver cirrhosis and chronic hepatitis B virus infection for 10 years. Physical examination revealed tenderness of the right abdomen. His liver function was abnormal: γ-glutamyltransferase, 110U/L (normal range,10-60), alkaline phosphatase, 135U/L (normal range, 45-125), glutamate dehydrogenase, 22.4U/L (normal range, 0-7.4), prealbumin, 11.7 mg/dL (normal range, 17-40). (Source: Gastroenterology)